AVINZA 30 mg 505
Generic Name: morphine
Pill imprint AVINZA 30 mg 505 has been identified as Avinza 30 mg/24 hours.
Avinza is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Avinza 30 mg/24 hours has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Avinza Images
- Generic Name:
- morphine
- Imprint:
-
AVINZA
30 mg 505 - Strength:
- 30 mg/24 hours
- Color:
- Yellow / White
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- ammonio methacrylate copolymers
fumaric acid
povidone
sodium lauryl sulfate
sugar spheres
magnesium silicate
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Ligand Pharmaceuticals
- National Drug Code (NDC):
- 64365-0505
Advertisement
More Avinza resources
- Avinza
- Avinza Extended-Release Capsules (Wolters Kluwer)
- Avinza (Cerner Multum)
- Avinza (Micromedex) - Includes Dosage Information
- Avinza (FDA)
Search Again
